Propeller Health, GSK expand collaboration for connected inhaler

Propeller Health and GlaxoSmithKline (NYSE:GSK) said today that the two companies are planning to commercialize GSK’s Ellipta inhaler with Propeller’s clip-on medication sensor and software platform.

The companies first announced their partnership in 2015 and in November last year the pair won 510(k) clearance from the FDA to market the Propeller plaftform with the Ellipta dry powder inhaler.

Get the full story at our sister site, Drug Delivery Business News.

The post Propeller Health, GSK expand collaboration for connected inhaler appeared first on MassDevice.

from MassDevice http://ift.tt/2v9nBGO